Envista Holdings Corp
Research Envista Holdings Corp (NVST) on Bullrun: valuation model: 22.5% overvalued, market cap USD 3.65B, P/E 39.5. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNVST
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal22.5% overvalued
- Market capUSD 3.65B
- P/E39.5
- Financial periodQ2 2026
- RevenueUSD 705.50M
- Net incomeUSD 38.70M
- Free cash flow-USD 15.80M
- Gross margin55.3%
Valuation Snapshot
Bullrun's latest valuation model marks Envista Holdings Corp as 22.5% overvalued; latest market cap is USD 3.65B; P/E is 39.5.
Peer valuation comparison
Latest P/E is 39.47x versus a Healthcare sector median of 24.6x (60.5% above).
Latest P/E is 39.47x versus a United States median of 23.85x (65.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.72B | USD 47.00M | USD 230.40M | 54.7% | 0.28 | USD 1.21B | USD 1.45B | USD 3.11B |
| FY2024 | USD 2.51B | -USD 1.12B | USD 302.70M | 54.7% | -6.5 | USD 1.07B | USD 1.39B | USD 2.93B |
| FY2023 | USD 2.57B | -USD 100.20M | USD 217.50M | 56.1% | -0.6 | USD 940.00M | USD 1.51B | USD 4.17B |
| FY2022 | USD 2.57B | USD 243.10M | USD 107.00M | 57.4% | 1.37 | USD 606.90M | USD 1.38B | USD 4.21B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 3.65B | 39.5 | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.56B | 80.4 | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.32B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 4.12B | 22.3 | n/a | n/a |
| 2022 | 2022-12-30 | USD 5.49B | 25.1 | n/a | n/a |
| 2021 | 2021-12-31 | USD 7.28B | 24.4 | n/a | n/a |
About Envista Holdings Corp
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Envista Holdings Corp overvalued or undervalued?
Bullrun's valuation model currently marks Envista Holdings Corp as 22.5% overvalued.
What is Envista Holdings Corp's market cap?
Envista Holdings Corp's market capitalization is USD 3.65B.
What is Envista Holdings Corp's P/E ratio?
Envista Holdings Corp's price-to-earnings (P/E) ratio is 39.5.
What does Envista Holdings Corp do?
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.